Published in PLoS Negl Trop Dis on November 17, 2009
Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: the case of lassa fever. PLoS Negl Trop Dis (2015) 0.96
Multifunctional nature of the arenavirus RING finger protein Z. Viruses (2012) 0.92
Rat-atouille: A Mixed Method Study to Characterize Rodent Hunting and Consumption in the Context of Lassa Fever. Ecohealth (2016) 0.85
Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali. Emerg Infect Dis (2016) 0.81
Moving interdisciplinary science forward: integrating participatory modelling with mathematical modelling of zoonotic disease in Africa. Infect Dis Poverty (2016) 0.81
Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate. J Virol (2013) 0.76
At Home with Mastomys and Rattus: Human-Rodent Interactions and Potential for Primary Transmission of Lassa Virus in Domestic Spaces. Am J Trop Med Hyg (2017) 0.75
A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis (1987) 5.27
Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg (1970) 4.96
Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.28
ELISA for the detection of antibodies to Ebola viruses. J Infect Dis (1999) 3.92
A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg (1973) 3.71
Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg (1972) 3.44
Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ (1995) 3.21
Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg (1974) 2.95
Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. Emerg Infect Dis (2000) 2.69
New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral Res (2007) 2.47
Lassa virus. Crit Rev Clin Lab Sci (2004) 2.27
Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. Vector Borne Zoonotic Dis (2001) 2.07
Mastomys natalensis and Lassa fever, West Africa. Emerg Infect Dis (2006) 1.94
Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies. Am J Trop Med Hyg (1974) 1.92
Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am J Trop Med Hyg (1996) 1.70
The first case of Lassa fever imported from Mali to the United Kingdom, February 2009. Euro Surveill (2009) 1.63
Effect of environmental factors on aerosol-induced Lassa virus infection. J Med Virol (1984) 1.47
Lassa fever in Onitsha, East Central State, Nigeria in 1974. Bull World Health Organ (1975) 1.44
Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen. J Med Virol (1993) 1.43
Lessons from nosocomial viral haemorrhagic fever outbreaks. Br Med Bull (2005) 1.39
Recent isolations of Lassa virus from Nigerian rodents. Bull World Health Organ (1975) 1.31
Short communication: Lassa fever in Sierra Leone: UN peacekeepers are at risk. Trop Med Int Health (2001) 1.26
A case of Lassa fever: clinical and virological findings. Br Med J (Clin Res Ed) (1982) 1.22
Fluctuation of abundance and Lassa virus prevalence in Mastomys natalensis in Guinea, West Africa. Vector Borne Zoonotic Dis (2007) 1.14
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates. Vaccine (2008) 1.09
Endemic Lassa fever in Liberia. I. Clinical and epidemiological aspects at Curran Lutheran Hospital, Zorzor, Liberia. Trans R Soc Trop Med Hyg (1984) 1.03
[Detection of anti-Lassa antibodies in the Western Forest area of the Ivory Coast]. Med Trop (Mars) (2006) 0.94
A survey for antibodies to Lassa virus among health workers in Nigeria. Trans R Soc Trop Med Hyg (1997) 0.84
The arenaviruses. J Am Vet Med Assoc (2005) 0.84
Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med (2014) 16.45
Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2014) 11.87
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet (2006) 10.91
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. N Engl J Med (2016) 6.22
Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J (2011) 5.65
Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med (2014) 4.79
Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic. J Infect Dis (2005) 4.75
The threat of artemisinin-resistant malaria. N Engl J Med (2011) 4.15
Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med (2005) 3.68
The dynamics of measles in sub-Saharan Africa. Nature (2008) 3.35
Routine Amoxicillin for Uncomplicated Severe Acute Malnutrition in Children. N Engl J Med (2016) 2.72
Hantavirus in African wood mouse, Guinea. Emerg Infect Dis (2006) 2.49
Novel hantavirus sequences in Shrew, Guinea. Emerg Infect Dis (2007) 2.44
Operational response to malaria epidemics: are rapid diagnostic tests cost-effective? Trop Med Int Health (2006) 2.39
Estimates of measles case fatality ratios: a comprehensive review of community-based studies. Int J Epidemiol (2009) 2.28
Use of Vibrio cholerae vaccine in an outbreak in Guinea. N Engl J Med (2014) 2.24
Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial. Lancet Infect Dis (2010) 2.24
Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis (2005) 2.06
Strategies for containing a global influenza pandemic. Vaccine (2006) 1.96
Mastomys natalensis and Lassa fever, West Africa. Emerg Infect Dis (2006) 1.94
The primacy of public health considerations in defining poor quality medicines. PLoS Med (2011) 1.91
Evaluation of three parasite lactate dehydrogenase-based rapid diagnostic tests for the diagnosis of falciparum and vivax malaria. Malar J (2009) 1.86
Mind the gaps--the epidemiology of poor-quality anti-malarials in the malarious world--analysis of the WorldWide Antimalarial Resistance Network database. Malar J (2014) 1.86
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority. Malar J (2011) 1.76
Meningitis serogroup W135 outbreak, Burkina Faso, 2002. Emerg Infect Dis (2007) 1.75
The case for reactive mass oral cholera vaccinations. PLoS Negl Trop Dis (2011) 1.70
Prioritization of influenza pandemic vaccination to minimize years of life lost. J Infect Dis (2008) 1.69
Measuring the performance of vaccination programs using cross-sectional surveys: a likelihood framework and retrospective analysis. PLoS Med (2011) 1.57
Mapping the aetiology of non-malarial febrile illness in Southeast Asia through a systematic review--terra incognita impairing treatment policies. PLoS One (2012) 1.56
World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs. Malar J (2007) 1.56
Evaluation of the benefits and risks of introducing Ebola community care centers, Sierra Leone. Emerg Infect Dis (2015) 1.56
Epizootic emergence of Usutu virus in wild and captive birds in Germany. PLoS One (2012) 1.55
Late vaccination reinforcement during a measles epidemic in Niamey, Niger (2003-2004). Vaccine (2006) 1.53
Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems. Lancet Infect Dis (2012) 1.53
A long-lasting measles epidemic in Maroua, Cameroon 2008-2009: mass vaccination as response to the epidemic. J Infect Dis (2011) 1.45
Rural-urban gradient in seasonal forcing of measles transmission in Niger. Proc Biol Sci (2010) 1.45
A comparison of cluster and systematic sampling methods for measuring crude mortality. Bull World Health Organ (2006) 1.44
Medication sales and syndromic surveillance, France. Emerg Infect Dis (2006) 1.42
Lessons and challenges for measles control from unexpected large outbreak, Malawi. Emerg Infect Dis (2013) 1.40
Poliomyelitis outbreak, Pointe-Noire, Republic of the Congo, September 2010-February 2011. Emerg Infect Dis (2011) 1.39
Bleach sedimentation: an opportunity to optimize smear microscopy for tuberculosis diagnosis in settings of high prevalence of HIV. Clin Infect Dis (2008) 1.38
First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012. PLoS Negl Trop Dis (2013) 1.37
Novel arenavirus sequences in Hylomyscus sp. and Mus (Nannomys) setulosus from Côte d'Ivoire: implications for evolution of arenaviruses in Africa. PLoS One (2011) 1.32
Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea. PLoS Med (2013) 1.29
Prevalence of Buruli ulcer in Akonolinga health district, Cameroon: results of a cross sectional survey. PLoS Negl Trop Dis (2009) 1.24
Trauma-related psychological disorders among Palestinian children and adults in Gaza and West Bank, 2005-2008. Int J Ment Health Syst (2009) 1.23
Evaluation of psychological support for victims of sexual violence in a conflict setting: results from Brazzaville, Congo. Int J Ment Health Syst (2009) 1.23
Delayed 2009 pandemic influenza A virus subtype H1N1 circulation in West Africa, May 2009-April 2010. J Infect Dis (2012) 1.22
Research in complex humanitarian emergencies: the Médecins Sans Frontières/Epicentre experience. PLoS Med (2008) 1.20
Prognostic accuracy of WHO growth standards to predict mortality in a large-scale nutritional program in Niger. PLoS Med (2009) 1.17
Quantitative analysis of particles, genomes and infectious particles in supernatants of haemorrhagic fever virus cell cultures. Virol J (2011) 1.16
Integrating mental health into primary care for displaced populations: the experience of Mindanao, Philippines. Confl Health (2011) 1.16
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool. Antimicrob Agents Chemother (2013) 1.15
Health care seeking behavior for diarrhea in children under 5 in rural Niger: results of a cross-sectional survey. BMC Public Health (2011) 1.15
Current molecular epidemiology of Lassa virus in Nigeria. J Clin Microbiol (2010) 1.15
Key strategies for reducing spread of avian influenza among commercial poultry holdings: lessons for transmission to humans. Proc Biol Sci (2006) 1.15
Urban cholera transmission hotspots and their implications for reactive vaccination: evidence from Bissau city, Guinea bissau. PLoS Negl Trop Dis (2012) 1.14
Early parasitological response following artemisinin-containing regimens: a critical review of the literature. Malar J (2013) 1.14
Fluctuation of abundance and Lassa virus prevalence in Mastomys natalensis in Guinea, West Africa. Vector Borne Zoonotic Dis (2007) 1.14
Prevalence study of yaws in the Democratic Republic of Congo using the lot quality assurance sampling method. PLoS One (2009) 1.14
Factors associated with severe preeclampsia and eclampsia in Jahun, Nigeria. Int J Womens Health (2013) 1.14
Spatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum. Malar J (2013) 1.11
Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN). Malar J (2010) 1.11
Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones. Virology (2004) 1.09
Mortality risk among children admitted in a large-scale nutritional program in Niger, 2006. PLoS One (2009) 1.07
Does the effectiveness of control measures depend on the influenza pandemic profile? PLoS One (2008) 1.05
Reducing wasting in young children with preventive supplementation: a cohort study in Niger. Pediatrics (2010) 1.04
Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa: systematic review and meta-analysis. Lancet Infect Dis (2009) 1.04
Effectiveness of ready-to-use therapeutic food compared to a corn/soy-blend-based pre-mix for the treatment of childhood moderate acute malnutrition in Niger. J Trop Pediatr (2010) 1.04
Measles in Democratic Republic of Congo: an outbreak description from Katanga, 2010-2011. BMC Infect Dis (2013) 1.03
Performance of a histidine-rich protein 2 rapid diagnostic test, Paracheck Pf®, for detection of malaria infections in Ugandan pregnant women. Am J Trop Med Hyg (2012) 1.03
Evaluation of a rapid test for the diagnosis of cholera in the absence of a gold standard. PLoS One (2012) 1.02
Measles outbreak response immunization is context-specific: insight from the recent experience of Médecins Sans Frontières. PLoS Med (2013) 1.02
Challenges in measuring measles case fatality ratios in settings without vital registration. Emerg Themes Epidemiol (2010) 1.01
The Colombian conflict: a description of a mental health program in the Department of Tolima. Confl Health (2009) 1.00
Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda. Malar J (2012) 1.00
Should outbreak response immunization be recommended for measles outbreaks in middle- and low-income countries? An update. J Infect Dis (2011) 1.00
Serological evidence of human hantavirus infections in Guinea, West Africa. J Infect Dis (2010) 1.00
Trends in antimalarial drug use in Africa. Am J Trop Med Hyg (2013) 0.99
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. BMC Med (2015) 0.99
Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières. PLoS Med (2008) 0.98
Malaria in infants aged less than six months - is it an area of unmet medical need? Malar J (2012) 0.98
Development and deployment of a rapid recombinase polymerase amplification Ebola virus detection assay in Guinea in 2015. Euro Surveill (2015) 0.97